Lin, Jianjun,
Lin, Ke,
Huang, Lijiang,
Jiang, Yongsheng,
Ding, Xiaoxiao,
Luo, Wu,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Liang, Guang,
Qian, Jianchang,
Wang, Yi (2022) /TLR4/MyD88 activation by physically interacting with TLR4 and MD2 in
vitro. Genetic loss of MD2
Yagudin, T,
Zhao, Y,
Gao, HY,
Zhang, Y,
Yang, Y,
Zhang, XF,
Ma, WB,
Daba, TM,
Ishmetov, V,
Kang, K,
Yang, BF,
Pan, ZW (2021) -exposed cardiomyocytes in
vitro. Overexpression of iASPP reduced the infarct size and cardiomyocyte apoptosis of mice
KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022) . The
structures of the synthesized compounds were established by IR, PMR, and 13C NMR spectroscopy. In
vitroBulgakova, NA,
Vasilyeva, NA,
Imelbaeva, EA,
Shikova, YV,
Vasiliev, EA,
Salikhova, DI (2021) according to level 1
tests (
tests for confirming immunodeficiency), immunoglobulins (Ig A, M, G
prediction was constructed and thirdly the computer risk assessment model was
tested on 50 patients with ACS
Valeeva, L.A.,
Davlyatova, G.G.,
Shabalina, Yu.V.,
Isakova, A.V.,
Khaliullin, F.A.,
Nikitina, I.L. (2016) -suspension
tests (TST) and forced swimming
tests (FST) found that 2-[3-methyl-7-(thietanyl-3)-1-ethylxanthinyl-8
. Images from the public LIDC/IDRI database were used to
test the model. The efficiency analysis showed
Zhandabayeva, MA,
Kozhanova, KK,
Boshkayeva, AK,
Kataev, VA,
Ustenova, GO,
Gemejiyeva, NG,
Iskakbayeva, ZA (2021) , standard
test strains of microorganisms were used: Staphylococcus aureus ATCC 6538-P, Escherichia coli ATCC